Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Pearson Medical Technologies Introduces m:Print Bar Code Labeling Software v4 for Pharmacy Drug Supply Chain Security Act (DSCSA) Compliance
-
$GODL - MEXC Listing & Celebratory Campaign
-
$GODL - MEXC Listing & Celebratory Campaign
-
Plains All American Reports Third-Quarter 2024 Results
-
InflaRx Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Notification of managers’ transactions
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
"Little Lanterns" Brighten Up the Path to Wealthiness with the Support from State Grid Wuwei Power Supply Company
-
"Little Lanterns" Brighten Up the Path to Wealthiness with the Support from State Grid Wuwei Power Supply Company
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 07 11 2024] - (CGWL)
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
Invesco Ltd: Form 8.3 - DS Smith PLC; Public dealing disclosure
-
Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
Prospect Capital Announces Financial Results for Fiscal September 2024 Quarter
-
NuVista Energy Ltd. Announces Strong Third Quarter 2024 Financial and Operating Results, LNG Agreement, 2025 Budget, and Enhanced Shareholder Return Strategy
-
Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024
-
Onex Reports Third Quarter 2024 Results
-
Seer to Participate in Upcoming November Investor Conferences
-
Ultralife Corporation Reports Third Quarter Results
-
Velocity One Signs Merger Agreement with EMCORE (EMKR)
-
Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook
-
BioXcel Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024
-
Torram Unveils Groundbreaking Infrastructure Tailored to Usher in a New Era of Bitcoin DeFi
-
CompoSecure Reports Strong Third Quarter 2024 Financial Results
-
Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages PACS Group, Inc. (NYSE: PACS) Investors with losses to Contact the Firm
-
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
-
Bright Peak Therapeutics Presents New Data at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
-
Onex Corporation Announces Substantial Issuer Bid for up to $400 MILLION of its Subordinate Voting Shares
-
Akero Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Capital Clean Energy Carriers Corp. Announces Third Quarter 2024 Financial Results
-
Torram Unveils Groundbreaking Infrastructure Tailored to Usher in a New Era of Bitcoin DeFi
-
illumin Reports Third Quarter 2024 Financial Results
-
Ashland to host live 2024 strategy update event for analysts and investors
-
Alliance Witan PLC - Net Asset Value
-
Immunocore to present at upcoming investor conferences
-
Perella Weinberg Reports Third Quarter 2024 Results
-
Brookfield Renewable Announces Record Third Quarter Results
-
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
-
Form 8.3 - Learning Technologies Group Plc
-
TransUnion Declares Third Quarter 2024 Dividend of $0.105 per Share
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
Ocugen Provides Business Update with Third Quarter 2024 Financial Results
-
Brookfield Business Partners Reports Third Quarter 2024 Results
-
XT Announcement on Listing PUNCH (One Punch Cat)
-
Y-mAbs Reports Third Quarter 2024 Financial Results and Recent Corporate Developments
-
XT Announcement on Launching BURT (BURT)
